DrugPatentWatch has been named to Genetic Engineering News‘ Best of the Web list. The review by Genetic Engineering News profile highlighted the “new training modules designed to help you find…
The post DrugPatentWatch named “Best of the Web” by Geneti…
DrugPatentWatch named “Best of the Web” by Genetic Engineering News Read Post »
DrugPatentWatch publisher Yali Friedman, Ph.D. will be speaking at the 15th Edition Pharma Resource Planning and Portfolio Optimization Conference. The event is from from April 25-26, 2022 at the Sheraton…
The post Join DrugPatentWatch at the 15th Phar…
This is a guest post by Ray Miller and Megan E. Bowers, Ph.D. at DLA Piper. Ray may be contacted at [email protected]. When it comes to protecting therapeutic assets, I…
The post The value of method of use patent claims in protecting your the…
The value of method of use patent claims in protecting your therapeutic assets Read Post »
FEATURED ARTICLE Branded Generics Promise Profits for Drugmakers, Peace of Mind for Patients Developing nations offer welcoming and growing markets as Abbott focuses exclusively on reformulating and marketing off-patent medications…
The post DrugPatent…
Drugs contain ingredients with therapeutic activity, so-called “active ingredients” as well as inactive ingredients. These inactive ingredients, called excipients, are included in oral products for various reasons, such as to…
The post 2 Strategies to …
2 Strategies to Grow Your Excipient Business by Tracking Drug Patents Read Post »
DrugPatentWatch developed this course to help users better understand the complexities and common strategies around brand erosion and generic entry. The positive responses received made it apparent that the course…
The post Free Online Course on Drug P…
Free Online Course on Drug Patents, Generic and Branded Drugs Read Post »
DrugPatentWatch has been ranked the “Best Biopharmaceuticals Commercial Business Intelligence Platform” by Global Health & Pharma News This award is dedicated to honoring the innovation, determination and outstanding levels of…
The post DrugPatentWatch…
DrugPatentWatch Ranked Best Biopharmaceuticals Commercial Business Intelligence Platform Read Post »
DrugPatentWatch’s Custom Market Surveillance provides you with a robust platform to monitor your business opportunities from every angle. You’re monitoring your business, but you’re too busy to sift through data.…
The post DrugPatentWatch Custom Market…
Before the passage of the Biologic Patent Transparency Act DrugPatentWatch’s biologic patent data was cited as a reason why the law should not be passed. Thankfully, the Act advanced, and…
The post Updating the DrugPatentWatch Biologics Module appeared…
This paper was originally published by Andreas H. Göller, Lara Kuhnke, Floriane Montanari, Anne Bonin, Sebastian Schneckener, Antoniuster Laak, Jörg Wichard, Mario Lobell, and Alexander Hillisch in Drug Discovery Today…
The post Bayer’s in silico ADMET…